Table 4 TAVR planning and procedure
Case | Valve anatomy | TTE AVA (cm2) | TTE transvalvular gradient peak/mean (mmHg) | CT aortic annulus area (mm2) | CT aortic annulus perimeter (mm) | CT perimeter derived diameter (mm) | CT LVOT area (mm2) | CT LVOT perimeter (mm) | THV | Contrast (mL) | Fluoroscopy time (min) | Introducer main vascular access | through-and-through wire technique (radial-femoral) | Access protection | Local anesthesia | Main access closure | Pre-dilatation | Post-dilatation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Tricuspid | 0.9 | 74/43 | 444.9 | 76.25 | 276.8 | 65.8 | PORTICO n.27 | 180 | 29.47 | 19F St. Jude | Yes | Left omeral artery | Yes | Proglidex2 preclosing | No | No | |
2 | Tricuspid | 0.8 | 75/45 | 408.3 | 73.3 | 23.3 | 268.1 | 62.1 | SAPIEN 3 n. 23 | 90 | 20.35 | 14F eSheath# | No | Omolateral | Yes | Prostar XL preclosing | No | Yes (23 mm) |
3 | Bicuspid type 1 L-R with calcific raphe | N/A | 84/50 | 492.3 | 82.5 | 26.7 | 457.1 | 79 | EVOLUT R 34 mm | 250 | 37.26 | 20F Gore Dryseal | No | Omolateral | Yes | Proglidex2 preclosing | Yes (23 mm) | Yes (24 mm) |
4 | Tricuspid | 0.9 | 70/40 | 428.8 | 74.6 | 23.7 | 430.2 | 74.7 | MYVAL 24.5 mm | 120 | 18.14 | Python 14F# | No | Omolateral | Yes | Prostar XL preclosing | Yes (20 mm) | No |
5 | Tricuspid | 0.8 | 37/22* | 462.7 | 76.7 | 24.4 | 433 | 74.7 | MYVAL 26 mm | 150 | 20.41 | Python 14F# | No | Crossover (femoral contralateral) | Yes | Proglidex2 preclosing | Yes (20 mm) | No |